patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
tralokinumab
Marketedupdated 2mo agoby LEO Pharma Inc
Approvedcommunity read0 votes
all catalysts(7)
approval · 7
Dec 27, 2021
approval
ADBRY (TRALOKINUMAB) — FDA approval
tralokinumab
→
Jul 27, 2022
approval
ADBRY (TRALOKINUMAB) — FDA approval
tralokinumab
→
Jun 2, 2023
approval
ADBRY (TRALOKINUMAB) — FDA approval
tralokinumab
→
Dec 14, 2023
approval
ADBRY (TRALOKINUMAB) — FDA approval
tralokinumab
→
Jun 12, 2024
approval
ADBRY (TRALOKINUMAB) — FDA approval
tralokinumab
→
Dec 12, 2025
approval
ADBRY (TRALOKINUMAB) — FDA approval
tralokinumab
→
Dec 17, 2025
approval
ADBRY (TRALOKINUMAB) — FDA approval
tralokinumab
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that